Burden of Wilson Disease among patients and care partners in the United States: results from a cross-sectional survey

References

• Bandmann O, Weiss KH, Kaler SG. Wilson’s disease and other neurological copper disorders. Lancet Neurol. 2015;14(1):103–113. doi: 10.1016/S1474-4422(14)70190-5.
   PubMed Web of Science ®Google Scholar
• Dress A, Theodore-Oklota C, Egan S, et al. The patient-reported experience of living with Wilson disease. Future Rare Diseases. 2021;1(3) doi: 10.2217/frd-2021-0003.
   Google Scholar
• Ranucci G, Polishchuck R, Iorio R. Wilson’s disease: prospective developments towards new therapies. World J Gastroenterol. 2017;23(30):5451–5456. doi: 10.3748/wjg.v23.i30.5451.
   PubMed Web of Science ®Google Scholar
• Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet. 2006;120(2):151–159. doi: 10.1007/s00439-006-0202-5.
   PubMed Web of Science ®Google Scholar
• Członkowska A, Litwin T, Dusek P, et al. Wilson disease. Nat Rev Dis Primers. 2018;4(1):21. doi: 10.1038/s41572-018-0018-3.
   PubMedGoogle Scholar
• Boga S, Ala A, Schilsky ML. Hepatic features of Wilson disease. Handb Clin Neurol. 2017;142:91–99. doi: 10.1016/B978-0-444-63625-6.00009-4.
   PubMedGoogle Scholar
• Camarata MA, Ala A, Coskun AK, et al. The effect of mental health, neurological disease, and liver disease on quality of life in patients with wilson disease. J Acad Consult Liaison Psychiatry. 2021;62(5):528–537. doi: 10.1016/j.jaclp.2021.04.004.
   PubMedGoogle Scholar
• Sandahl TD, Laursen TL, Munk DE, et al. The prevalence of Wilson’s disease: an update. Hepatology. 2020;71(2):722–732. doi: 10.1002/hep.30911.
   PubMed Web of Science ®Google Scholar
• Miloh T, Graper M, Michael S. Evaluating diagnosis and management gaps in Wilson disease: results from a qualitative patient survey. Adv Rare Dis. 2018;4(1) doi: 10.12715/ard.2014.3.1.
   Google Scholar
• Masełbas W, Członkowska A, Litwin T, et al. Persistence with treatment for Wilson disease: a retrospective study. BMC Neurol. 2019;19(1):278. doi: 10.1186/s12883-019-1502-4.
   PubMed Web of Science ®Google Scholar
• Maselbas W, Litwin T, Czlonkowska A. Social and demographic characteristics of a polish cohort with Wilson disease and the impact of treatment persistence. Orphanet J Rare Dis. 2019;14(1):167. doi: 10.1186/s13023-019-1133-2.
   PubMedGoogle Scholar
• Aggarwal A, Bhatt M. Advances in treatment of Wilson disease. Tremor Other Hyperkinet Mov. 2018;8(0):525. doi: 10.7916/D841881D.
   PubMedGoogle Scholar
• Yuan XZ, Yang RM, Wang XP. Management perspective of Wilson’s disease: early diagnosis and individualized therapy. Curr Neuropharmacol. 2021;19(4):465–485. doi: 10.2174/1570159X18666200429233517.
   PubMed Web of Science ®Google Scholar
• Balijepalli C, Yan K, Gullapalli L, et al. Quality of life in Wilson’s disease: a systematic literature review. J Health Econ Outcomes Res. 2021;8(2):105–113. doi: 10.36469/jheor.2021.29987.
   PubMedGoogle Scholar
• Merle U, Schaefer M, Ferenci P, et al. Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study. Gut. 2007;56(1):115–120. doi: 10.1136/gut.2005.087262.
   PubMed Web of Science ®Google Scholar
• Dev S, Kruse RL, Hamilton JP, et al. Wilson disease: update on pathophysiology and treatment. Front Cell Dev Biol. 2022;10:871877. doi: 10.3389/fcell.2022.871877.
   PubMed Web of Science ®Google Scholar
• Karantzoulis S, Heuer K, Sparling N, et al. The patient experience of Wilson disease: a conceptual model based on qualitative research. Orphanet J Rare Dis. 2021;16(1):437. doi: 10.1186/s13023-021-02059-x.
   PubMed Web of Science ®Google Scholar
• Rustgi VK, Gupta K, Tait C, et al. Wilson’s disease: an analysis of health care use and cost burden of commercially insured adults in the United States. Hepatol Commun. 2022;6(2):389–398. doi: 10.1002/hep4.1812.
   PubMed Web of Science ®Google Scholar
• Dening TR, Berrios GE. Wilson’s disease. Psychiatric symptoms in 195 cases. Arch Gen Psychiatry. 1989;46(12):1126–1134. doi: 10.1001/archpsyc.1989.01810120068011.
   PubMed Web of Science ®Google Scholar
• Svetel M, Potrebić A, Pekmezović T, et al. Neuropsychiatric aspects of treated Wilson’s disease. Parkinsonism Relat Disord. 2009;15(10):772–775. doi: 10.1016/j.parkreldis.2009.01.010.
   PubMed Web of Science ®Google Scholar
• Svetel M, Pekmezović T, Tomić A, et al. Quality of life in patients with treated and clinically stable Wilson’s disease. Mov Disord. 2011;26(8):1503–1508. doi: 10.1002/mds.23608.
   PubMed Web of Science ®Google Scholar
• Schaefer M, Gotthardt DN, Ganion N, et al. Wilson disease: health-related quality of life and risk for depression. Clin Res Hepatol Gastroenterol. 2016;40(3):349–356. doi: 10.1016/j.clinre.2015.09.007.
   PubMed Web of Science ®Google Scholar
• LaVeist TA, Pérez-Stable EJ, Richard P, et al. The economic burden of racial, ethnic, and educational health inequities in the US. JAMA. 2023;329(19):1682–1692. doi: 10.1001/jama.2023.5965.
   PubMed Web of Science ®Google Scholar
• Sutcliffe RP, Maguire DD, Muiesan P, et al. Liver transplantation for Wilson’s disease: long-term results and quality-of-life assessment. Transplantation. 2003;75(7):1003–1006. doi: 10.1097/01.TP.0000055830.82799.B1.
   PubMed Web of Science ®Google Scholar
• Beinhardt S, Leiss W, Stättermayer AF, et al. Long-term outcomes of patients with Wilson disease in a large Austrian cohort. Clin Gastroenterol Hepatol. 2014;12(4):683–689. doi: 10.1016/j.cgh.2013.09.025.
   PubMed Web of Science ®Google Scholar
• Wu P, Zheng Y, Fan X, et al. Predictors of caregiver burden in patients with neurologic Wilson disease. J Int Med Res. 2020;48(6):300060520930156. doi: 10.1177/0300060520930156.
   PubMed Web of Science ®Google Scholar
• Unavane O, Tiwari K, Nagral A, et al. Quality of life of patients with Wilson’s disease and their families. J Clin Exp Hepatol. 2022;12(2):461–466. doi: 10.1016/j.jceh.2021.05.013.
   PubMed Web of Science ®Google Scholar
• Schulz R, Beach SR. Caregiving as a risk factor for mortality: the caregiver health effects study. JAMA. 1999;282(23):2215–2219. doi: 10.1001/jama.282.23.2215.
   PubMed Web of Science ®Google Scholar
• Schulz R, Sherwood PR. Physical and mental health effects of family caregiving. Am J Nurs. 2008;108(9 Suppl):23–27; quiz 27. doi: 10.1097/01.NAJ.0000336406.45248.4c.
   PubMed Web of Science ®Google Scholar
• Bolge SC, Doan JF, Kannan H, et al. Association of insomnia with quality of life, work productivity, and activity impairment. Qual Life Res. 2009;18(4):415–422. doi: 10.1007/s11136-009-9462-6.
   PubMed Web of Science ®Google Scholar
• DiBonaventura MD, Wagner JS, Yuan Y, et al. Humanistic and economic impacts of hepatitis C infection in the United States. J Med Econ. 2010;13(4):709–718. doi: 10.3111/13696998.2010.535576.
   PubMedGoogle Scholar
• Finkelstein EA, Allaire BT, Dibonaventura MD, et al. Direct and indirect costs and potential cost savings of laparoscopic adjustable gastric banding among obese patients with diabetes. J Occup Environ Med. 2011;53(9):1025–1029. doi: 10.1097/JOM.0b013e318229aae4.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi: 10.1016/0021-9681(87)90171-8.
   PubMedGoogle Scholar
• Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
   PubMed Web of Science ®Google Scholar
• Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the patient health questionnaire (PHQ-9): a meta-analysis. CMAJ. 2012;184(3):E191–6. doi: 10.1503/cmaj.110829.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Kroenke K, Williams JBW, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. doi: 10.1001/archinte.166.10.1092.
   PubMed Web of Science ®Google Scholar
• Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736. doi: 10.1007/s11136-011-9903-x.
   PubMed Web of Science ®Google Scholar
• Członkowska A, Tarnacka B, Möller JC, et al. Unified wilson’s disease rating scale - a proposal for the neurological scoring of Wilson’s disease patients. Neurol Neurochir Pol. 2007;41(1):1–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17330175.
   PubMed Web of Science ®Google Scholar
• Unni EJ, Olson JL, Farris KB. Medication adherence reasons scale (MAR-Scale). Curr Med Res Opin. 2014;30(2):211–221. doi: 10.1185/03007995.2013.851075.
   PubMed Web of Science ®Google Scholar
• Given CW, Given B, Stommel M, et al. The caregiver reaction assessment (CRA) for caregivers to persons with chronic physical and mental impairments. Res Nurs Health. 1992;15(4):271–283. doi: 10.1002/nur.4770150406.
   PubMed Web of Science ®Google Scholar
• Nijboer C, Triemstra M, Tempelaar R, et al. Measuring both negative and positive reactions to giving care to cancer patients: psychometric qualities of the caregiver reaction assessment (CRA). Soc Sci Med. 1999;48(9):1259–1269. doi: 10.1016/s0277-9536(98)00426-2.
   PubMed Web of Science ®Google Scholar
• Reilly MC, Tanner A, Meltzer EO. Work, classroom and activity impairment instruments. Clin. Drug Invest. 1996;11(5):278–288. doi: 10.2165/00044011-199611050-00004.
   Web of Science ®Google Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–365. doi: 10.2165/00019053-199304050-00006.
   PubMed Web of Science ®Google Scholar
• Rubin DB. Using propensity scores to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol. 2001;2(3/4):169–188. doi: 10.1023/A:1020363010465.
   Google Scholar
• Frota NAF, Caramelli P, Barbosa ER. Cognitive impairment in Wilson’s disease. J Neuropsychiatry Clin Neurosci. 1992;4(3):349–350. doi: 10.1176/jnp.4.3.349
   PubMed Web of Science ®Google Scholar
• Leung M, Wu Lanzafame J, Medici V. Switching pharmacological treatment in Wilson disease: case report and recommendations. J Investig Med High Impact Case Rep. 2020;8:2324709619896876. doi: 10.1177/2324709619896876.
   Web of Science ®Google Scholar
• Teufel-Schäfer U, Forster C, Schaefer N. Low copper diet-A therapeutic option for Wilson disease? Children . 2022;9(8):1132. doi: 10.3390/children9081132.
   PubMedGoogle Scholar
• Członkowska A, Tarnacka B, Litwin T, et al. Wilson’s disease - Cause of mortality in 164 patients during 1992–2003 observation period. J Neurol. 2005;252(6):698–703. doi: 10.1007/s00415-005-0720-4.
   PubMed Web of Science ®Google Scholar
• Xu J, Deng Q, Qin Q, et al. Sleep disorders in Wilson disease: a systematic review and meta-analysis. J Clin Sleep Med. 2020;16(2):219–230. doi: 10.5664/jcsm.8170.
   PubMed Web of Science ®Google Scholar
• Nevsimalova S, Buskova J, Bruha R, et al. Sleep disorders in Wilson’s disease. Eur J Neurol. 2011;18(1):184–190. doi: 10.1111/j.1468-1331.2010.03106.x.
   PubMed Web of Science ®Google Scholar
• Tribl GG, Trindade MC, Bittencourt T, et al. Wilson’s disease with and without rapid eye movement sleep behavior disorder compared to healthy matched controls. Sleep Med. 2016;17:179–185. doi: 10.1016/j.sleep.2015.09.003.
   PubMed Web of Science ®Google Scholar
• Komal Kumar R, Taly A, Nair KPS, et al. Quality of life in Wilson′s disease. Ann Indian Acad Neurol. 2008;11(1):37–40. doi: 10.4103/0972-2327.40224.
   PubMed Web of Science ®Google Scholar
• Carta MG, Mura G, Sorbello O, et al. Quality of life and psychiatric symptoms in Wilson’s disease: the relevance of bipolar disorders. Clin Pract Epidemiol Ment Health. 2012;8:102–109. doi: 10.2174/1745017901208010102.
   PubMedGoogle Scholar
• Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci. 2011;13(1):7–23. doi: 10.31887/DCNS.2011.13.1/wkaton
   PubMedGoogle Scholar
• Menon B, Nayar R, Kumar S, et al. Parkinson’s disease, depression, and quality-of-life. Indian. Dialogues Clin Neurosci. 2011;13(1):7–23. doi: 10.4103/0253-7176.155611.
   PubMedGoogle Scholar
• Chu CH, Quan AML, McGilton KS. Depression and functional mobility decline in long term care home residents with dementia: a prospective cohort study. Can Geriatr J. 2021;24(4):325–331. doi: 10.5770/cgj.24.511.
   PubMed Web of Science ®Google Scholar
• Chevalier K, Rahli D, de Veyrac L, et al. Quality of life and depression in Wilson’s disease: a large prospective cross-sectional study. Orphanet J Rare Dis. 2023;18(1):168. doi: 10.1186/s13023-023-02777-4.
   PubMed Web of Science ®Google Scholar
• Martínez-Martín P, Forjaz MJ, Frades-Payo B, et al. Caregiver burden in Parkinson’s disease. Mov Disord. 2007;22(7):924–931; quiz 1060. doi: 10.1002/mds.21355.
   PubMed Web of Science ®Google Scholar
• Karakis I, Morton ML, Janocko NJ, et al. Caregiver burden in psychogenic non-epileptic seizures. Seizure. 2020;81:13–17. doi: 10.1016/j.seizure.2020.07.007.
   PubMed Web of Science ®Google Scholar
• Bayen E, Jourdan C, Ghout I, et al. Objective and subjective burden of informal caregivers 4 years after a severe traumatic brain injury: results from the Paris-TBI study. J Head Trauma Rehabil. 2016;31(5):E59–67. doi: 10.1097/HTR.0000000000000079.
   PubMed Web of Science ®Google Scholar
• Nemcikova M, Katreniakova Z, Nagyova I. Social support, positive caregiving experience, and caregiver burden in informal caregivers of older adults with dementia. Front Public Health. 2023;11:1104250. doi: 10.3389/fpubh.2023.1104250.
   PubMedGoogle Scholar
• Edwards NE, Scheetz PS. Predictors of burden for caregivers of patients with Parkinson’s disease. J Neurosci Nurs. 2002;34(4):184–190. doi: 10.1097/01376517-200208000-00003.
   PubMedGoogle Scholar
• Chiou CJ, Chang HY, Chen IP, et al. Social support and caregiving circumstances as predictors of caregiver burden in Taiwan. Arch Gerontol Geriatr. 2009;48(3):419–424. doi: 10.1016/j.archger.2008.04.001.
   PubMed Web of Science ®Google Scholar
• Skaff MM, Pearlin LI. Caregiving: role engulfment and the loss of self 1. Gerontologist. 1992;32(5):656–664. doi: 10.1093/geront/32.5.656.
   PubMed Web of Science ®Google Scholar
• Kim DJ. Relationships between caregiving stress, depression, and self-esteem in family caregivers of adults with a disability. Occup Ther Int. 2017;2017:1686143–1686149. doi: 10.1155/2017/1686143.
   PubMedGoogle Scholar
• Frota NAF, Caramelli P, Barbosa ER. Cognitive impairment in Wilson’s disease. Dement Neuropsychol. 2009;3(1):16–21. doi: 10.1590/S1980-57642009DN30100004.
   PubMedGoogle Scholar
• Litwin T, Dusek P, Szafrański T, et al. Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment. Ther Adv Psychopharmacol. 2018;8(7):199–211. doi: 10.1177/2045125318759461.
   PubMed Web of Science ®Google Scholar
• Gupta S, Goren A, Phillips AL, et al. Self-reported burden among caregivers of patients with multiple sclerosis. Int J MS Care. 2012;14(4):179–187. doi: 10.7224/1537-2073-14.4.179.
   PubMedGoogle Scholar
• Gupta S, Isherwood G, Jones K, et al. Productivity loss and resource utilization, and associated indirect and direct costs in individuals providing care for adults with schizophrenia in the EU5. Clinicoecon Outcomes Res. 2015;7:593–602. doi: 10.2147/CEOR.S94334.
   PubMed Web of Science ®Google Scholar
• 2021 National Healthcare Quality and Disparities Report [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021. Report No.: 21(22)-0054-EF; [cited 2023 Aug 13]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK578529/.
   Google Scholar
• The National Organization for Rare Disorders (NORD®). Rare Insights® Barriers to Rare Disease Diagnosis, Care and Treatment in the US: a 30-year comparative analysis [Internet]. 2020 [cited 2023 Aug 11]. Available from: https://rarediseases.org/wp-content/uploads/2022/10/NRD-2088-Barriers-30-Yr-Survey-Report_FNL-2.pdf.
   Google Scholar